How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?
about
Postoperative radiation in esophageal squamous cell carcinoma and target volume delineationEmerging treatment options for nasopharyngeal carcinomaPrognostic value of magnetic resonance imaging-detected cranial nerve invasion in nasopharyngeal carcinomaLong-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma.Comparison of radiological and clinical features of temporal lobe necrosis in nasopharyngeal carcinoma patients treated with 2D radiotherapy or intensity-modulated radiotherapyIs pretreatment Epstein-Barr virus DNA still associated with 6-year survival outcomes in locoregionally advanced nasopharyngeal carcinoma?Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.Does MRI-detected cranial nerve involvement affect the prognosis of locally advanced nasopharyngeal carcinoma treated with intensity modulated radiotherapy?IMRT combined with concurrent chemotherapy plus adjuvant chemotherapy versus IMRT combined with concurrent chemotherapy alone in patients with nasopharyngeal carcinomaA retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinomaClinical study of nasopharyngeal carcinoma treated by helical tomotherapy in China: 5-year outcomes.Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.Pretreatment lifestyle behaviors as survival predictors for patients with nasopharyngeal carcinoma.Prognostic value and staging classification of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.Friend leukemia virus integration 1 expression has prognostic significance in nasopharyngeal carcinoma.Low BRMS1 expression promotes nasopharyngeal carcinoma metastasis in vitro and in vivo and is associated with poor patient survivalDiabetes, prediabetes and the survival of nasopharyngeal carcinoma: a study of 5,860 patients.Prognoses and long-term outcomes of nasopharyngeal carcinoma in Han and Uyghur patients treated with intensity-modulated radiotherapy in the Xinjiang Autonomous Region of ChinaRadiotherapy concurrently with weekly cisplatin, followed by adjuvant chemotherapy, for N2-3 nasopharyngeal cancer: a multicenter trial of the Forum for Nuclear Cooperation in AsiaA novel statistical prognostic score model that includes serum CXCL5 levels and clinical classification predicts risk of disease progression and survival of nasopharyngeal carcinoma patients.Influence of gender and age on the survival of patients with nasopharyngeal carcinomaPrognostic significance of maximum primary tumor diameter in nasopharyngeal carcinoma.A comparison between the sixth and seventh editions of the UICC/AJCC staging system for nasopharyngeal carcinoma in a Chinese cohort.Prognostic factors and survival in patients with radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma.Primary tumor regression speed after radiotherapy and its prognostic significance in nasopharyngeal carcinoma: a retrospective study.MiR-101 sensitizes human nasopharyngeal carcinoma cells to radiation by targeting stathmin 1.The effect of adjuvant chemotherapy on survival in patients with residual nasopharyngeal carcinoma after undergoing concurrent chemoradiotherapyMiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinomaElevated high-sensitivity C-reactive protein levels predict decreased survival for nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy eraIs maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy?High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma.Leucopenia and treatment efficacy in advanced nasopharyngeal carcinoma.Incidence of and Risk Factors for Mastoiditis after Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma.The significant survival advantage of female sex in nasopharyngeal carcinoma: a propensity-matched analysis.A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma.Effect of Prolonged Radiotherapy Treatment Time on Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal CarcinomaPropensity-matched analysis of three different chemotherapy sequences in patients with locoregionally advanced nasopharyngeal carcinoma treated using intensity-modulated radiotherapy.Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy.Identification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone.Prognostic value of the primary lesion apparent diffusion coefficient (ADC) in nasopharyngeal carcinoma: a retrospective study of 541 cases.
P2860
Q26741018-D78954E5-AA04-4653-8E8F-28A002D67EECQ26995560-67C2E6E3-C945-4BE1-BA8C-CFBC2E467744Q30416507-BFC6FB1A-1884-4CCE-93C5-9056FC4D8A8BQ33425830-37E8626F-F4BC-41CC-B473-549290D184EFQ33683013-8A26A49C-4AF5-40CF-9336-A8163379349FQ33702316-B91AD83B-8200-4165-BFE7-1DDD735A3A9CQ33712856-6F2EB35C-1EA6-4A36-A415-6B1CCE41B198Q33806554-3388205E-30C3-4535-B38D-1259423CF8FDQ33889336-078C313F-4B31-4D8C-8D24-5985A634EA76Q33890586-D512D973-D34C-48F1-AC56-46EEDC9782A5Q33994022-1E22959E-0DA6-4490-9303-1036919C499DQ34159567-3C207D4E-EECD-4B3E-9054-69D30D781900Q34270787-615BE04D-A895-4554-9CD3-C5DE50BAC181Q34323090-8E9EECE9-7E0E-4F2F-ADE2-73107F18BC08Q34369337-762739CA-D519-41C0-B3AD-55ABE4FA9E27Q34397133-08A0D92B-4C64-4EC8-9D99-F7B80D8E5D16Q34414818-7F608057-222E-4A2C-B04B-D56888357B46Q34465715-73220EE8-D714-4984-A0EA-B1C0D4B5B323Q34494991-3319C5AB-1CC4-48CB-AE75-2A067D7CAB72Q34612497-BE36A550-8ED9-46FD-BA54-04E34CEB54CEQ34705381-0FC50E23-18B8-4D13-9143-6C33E65626B5Q34741772-10F31FEA-4C35-4CA6-85A8-CBD34108D062Q34764855-8B444FB7-0F60-48A2-820E-C2EEC9C7D511Q35075815-C5FB32C6-02B0-4732-BFC1-CF1264118356Q35103235-D51AC9AF-9C61-4678-BDF6-3C3CF9EE50F6Q35201698-019722D5-5989-43C9-9CFD-74E9054C8DD0Q35208691-34E13D6F-85F6-4E03-80CF-296E45AF6F42Q35225191-36CAA8DD-B6C4-4D73-87C6-AA8E25AC334CQ35391282-17F6A47E-CD24-4DBF-989E-432C8913D23DQ35521570-7417EF75-C417-4EE5-9581-B368A37362E4Q35583857-4CC157B4-E428-48C8-9F6A-B31B3E3AADCBQ35640038-80C31B83-061D-4EE6-B584-588D8C6B6F87Q35675444-1B00127F-1812-4F89-9479-0A1191FCB8B4Q35677945-7C3EC296-0F08-4C3A-859C-9EA414EDE845Q35732890-34192FEB-36EB-4BB0-AA10-91D0D6AB4100Q35823230-9335DDB6-D26B-4AD5-9506-A21A6D87EE25Q35823316-1D42550E-70FA-485D-A70D-F2BDC76A07D2Q35824278-1931F08A-843F-4659-BA52-349F177FAA12Q35851730-D775599E-B83F-4CBF-847C-E1483DE4600BQ35860283-5E11C255-7125-4D6B-8776-FD53F1DDC4D3
P2860
How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
How does intensity-modulated r ...... pharyngeal carcinoma patients?
@en
How does intensity-modulated r ...... pharyngeal carcinoma patients?
@nl
type
label
How does intensity-modulated r ...... pharyngeal carcinoma patients?
@en
How does intensity-modulated r ...... pharyngeal carcinoma patients?
@nl
prefLabel
How does intensity-modulated r ...... pharyngeal carcinoma patients?
@en
How does intensity-modulated r ...... pharyngeal carcinoma patients?
@nl
P2093
P1476
How does intensity-modulated r ...... pharyngeal carcinoma patients?
@en
P2093
Ai-Hua Lin
Li-Zhi Liu
Meng-Zhong Liu
Shu-Zhen Lai
Wen-Fei Li
Yuan-Yuan Chen
P304
P356
10.1016/J.IJROBP.2010.03.024
P407
P577
2010-07-17T00:00:00Z